- authorisedTherapeutic confirmatory (Phase III)
Effectiveness of a preventive strategy for cytomegalovirus infection guided differently from a universal prophylactic strategy in kidney transplant patients - CYTOPREV
This study compares different ways to prevent cytomegalovirus (CMV) infection after a kidney transplant. It tests a specific medicine, VALGANCICLOVIR VIATRIS, to see how well it works and if it's better than standard prevention to keep patients healthy.
France - recruitingPHASE4
Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients
This study looks at a new drug, Letermovir, combined with usual treatments for a common virus called CMV in people who have had lung transplants. We want to see if this combination clears the virus more effectively than standard treatment alone.
Canada